Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07084701

Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults With Sleep Deprivation: A Proof-of-Concept Study

This Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults with Sleep deprivation: A Proof-of-Concept Study aims to investigate the effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on memory and cognitive function in adults experiencing sleep deprivation(SD). Given the known impact of SD on cognitive performance, this study seeks to explore whether NSCLD, as a non-invasive intervention, can mitigate the cognitive impairments associated with SD.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tianjin Medical University General Hospital

Tianjin, China

Location status: Recruiting

About this study

Sleep deprivation (SD) is widespread in modern society, particularly among medical students, residents, and individuals in high-stress occupations. Numerous studies have demonstrated that acute sleep deprivation significantly impairs cognitive processes such as attention, working memory, and executive function. Even short-term cognitive impairment can have serious consequences, including impaired judgment, slowed reaction times, and increased error rates.

Currently, interventions targeting cognitive decline following sleep deprivation are limited. Common strategies primarily include medications (such as caffeine and modafinil) and restorative sleep. However, these methods have limitations in both clinical and real-life settings: on one hand, medications may lead to tolerance and side effects, and on the other hand, restorative sleep often cannot reverse cognitive impairment in the short term. Therefore, developing a safe, convenient, and rapidly effective non-pharmacological intervention is of great significance.

In recent years, the glymphatic system has garnered increasing attention. This system is believed to play a key role in clearing metabolic waste from the brain, regulating sleep structure, and maintaining neurocognitive function. Superficial craniocervical lymphatic drainage (SCLD) has been proposed as a potential mechanism to improve cognitive function by enhancing the flow of cerebrospinal fluid (CSF) and lymph, reducing neuroinflammation, and minimizing the accumulation of metabolic waste.

In June 2025, a study published in Nature provided the first in vivo evidence supporting this hypothesis. Researchers applied non-invasive mechanical stimulation to the superficial lymphatic system on the skin surface of the mouse neck, resulting in a doubling of CSF drainage efficiency to cervical lymph nodes and correction of impaired brain-lymphatic efflux function in aged mice. These findings provide direct mechanistic support for the potential application of non-invasive SCLD intervention in humans.

Therefore, this study aims to establish an acute sleep deprivation model in healthy adults and explore the immediate effects of NSCLD intervention on cognitive function, with the goal of providing preliminary clinical evidence for non-pharmacological intervention strategies related to the brain-lymphatic pathway.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • College student ≥18 years, all of whom have passed a standardized entrance examination;
  • No failed exams during the course of study;
  • Sleep deprivation;
  • In good health, with no mental or psychological disorders;
  • No recent use of medications that may affect memory and cognition;
  • Voluntary participation and able to undergo cognitive function and memory testing;
  • Informed consent provided

Exclusion criteria

  • Pregnant or breastfeeding women.
  • Presence of acute or chronic medical conditions (e.g., severe hypertension, diabetes, cardiovascular disease) that could confound the results.
  • History of craniocervical trauma or surgery.
  • Current use of sedative or anxiolytic medications that could influence sleep or cognitive function.
  • Participants who are unable to follow the procedures or complete the assessments

Treatment and study plan

Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD)

Device

Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.

sham-intervention treatment

Device

Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.

Primary outcomes

  1. Digit Span Test

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    Evaluate memory function. 1 point for each correct string of numbers. Total score: forward score + backward score. Higher scores mean a better outcome.

  2. Montreal Cognitive Assessment (MoCA)

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    The maximum score is 30 points. ≥26 points is normal. Higher scores mean a better outcome.

Secondary outcomes

  1. Changes in anxiety, stress, irritability, etc. before and after instant massage

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    use Multidimensional VAS Battery. 0 points are "not at all", and 100 points are "extremely strong" (points 0- 100)

  2. Brain metabolic markers and other metabolic indicators

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    Collect blood for analysis of Aβ42/40, T-Tau, p-tau217, Plasma cortisol, Salivary α-Amylase and β-Endorphin.

  3. EEG power in alpha, beta, delta and theta band

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    Measure the power of different frequency bands of EEG and compare the changes.

  4. Heart rate variability (HRV)

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    Analyze the different indicators of HRV, including RMSSD, LF, HF, LF/HF ratio, SDNN, etc.

  5. modified TOEFL iBT

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    Developed by English language professionals based on TOEFL difficulty and standards, with self-compiled test papers. Full marks: 100 points. To evaluate working memory, learning memory, attention allocation, information processing speed, executive functions (such as planning and monitoring), and the retrieval and integration of long-term memory, among other aspects.

  6. Computerized Cognitive Assessment

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    Use N-back task and Psychomotor vigilance task (PVT) ,measure metrics such as reaction time and accuracy rate.

  7. Functional magnetic resonance imaging (fMRI)

    Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period

    Using functional magnetic resonance imaging to evaluate brain functional activity.

Study contacts

Contact information is provided by the study sponsor or research team.

Tao Liu, MD

CONTACT

[email protected]

86-18302204804

Yuezheng Dou

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Tao Liu

Other

Collaborators

  • Tianjin Medical University General Hospital
  • Xuanwu Hospital, Beijing

Registry information

Acronym: NSCLD

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 24, 2025
Registry last updated
Jan 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.